Clinical Trials
12 trialsNCT01272037 2026-06-03
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT02926911 2026-05-12
COMET
Alliance Foundation Trials, LLC.
Phase NA Active not recruiting
NCT03317405 2026-05-04
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT01905046 2026-04-28
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT01266642 2026-03-11
Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT01349322 2026-03-05
Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Radiation Therapy Oncology Group
Phase 3 Active not recruiting
NCT03345420 2025-12-30
NOVEMBER
University of Utah
Phase 2 Completed
NCT00556907 2025-11-06
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast
University of Southern California
Phase NA Terminated
NCT03535506 2025-09-26
WI223281
Georgetown University
Phase 2 Terminated
NCT01841749 2025-09-12
CINNAMOME
Institut Bergonié
Completed
NCT00769379 2025-06-12
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
National Cancer Institute (NCI)
Phase 3 Completed
NCT01819233 2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA Completed